These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18445706)

  • 1. Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy.
    Colucci VJ; Berry BD
    Ann Pharmacother; 2008 Jun; 42(6):882-7. PubMed ID: 18445706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract]   [Full Text] [Related]  

  • 3. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
    Stahl SM; Grady MM; Moret C; Briley M
    CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
    Park P; Caballero J; Omidian H
    Ann Pharmacother; 2014 Jan; 48(1):86-92. PubMed ID: 24259607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants.
    Ashton AK; Longdon MC
    Am J Psychiatry; 2007 Jul; 164(7):1121-2. PubMed ID: 17606668
    [No Abstract]   [Full Text] [Related]  

  • 6. A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.
    Allgulander C; Nutt D; Detke M; Erickson J; Spann M; Walker D; Ball S; Russell J
    J Psychopharmacol; 2008 Jun; 22(4):417-25. PubMed ID: 18635722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.
    Hartford J; Kornstein S; Liebowitz M; Pigott T; Russell J; Detke M; Walker D; Ball S; Dunayevich E; Dinkel J; Erickson J
    Int Clin Psychopharmacol; 2007 May; 22(3):167-74. PubMed ID: 17414743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.
    Vis PM; van Baardewijk M; Einarson TR
    Ann Pharmacother; 2005 Nov; 39(11):1798-807. PubMed ID: 16189284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
    Muneoka K; Shirayama Y; Takigawa M; Shioda S
    Neurochem Res; 2009 Mar; 34(3):542-55. PubMed ID: 18751896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
    Hsiao MC; Liu CY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):576. PubMed ID: 17889418
    [No Abstract]   [Full Text] [Related]  

  • 11. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW; Lönn SL; Despiégel N
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
    Raskin J; Smith TR; Wong K; Pritchett YL; D'Souza DN; Iyengar S; Wernicke JF
    J Palliat Med; 2006 Feb; 9(1):29-40. PubMed ID: 16430342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
    Dell'Osso B; Nestadt G; Allen A; Hollander E
    J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
    Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM
    J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
    Bymaster FP; Dreshfield-Ahmad LJ; Threlkeld PG; Shaw JL; Thompson L; Nelson DL; Hemrick-Luecke SK; Wong DT
    Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.
    Strombom I; Wernicke JF; Seeger J; D'Souza DN; Acharya N
    Curr Drug Saf; 2008 May; 3(2):154-62. PubMed ID: 18690993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder.
    van Baardewijk M; Vis PM; Einarson TR
    Curr Med Res Opin; 2005 Aug; 21(8):1271-9. PubMed ID: 16083537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
    Nordström G; Despiegel N; Marteau F; Danchenko N; Maman K
    J Med Econ; 2010; 13(3):516-26. PubMed ID: 20698748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine.
    Scheinfeld N
    Dermatol Online J; 2013 Nov; 19(11):20616. PubMed ID: 24314785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.